Value of red cell distribution width for assessing disease activity in Crohn's disease

American Journal of the Medical Sciences

Volumn 349, Issue 1, 2015, Pages 42-45

  Hu, Dong ^a   Ren, Jianan ^a   Wang, Gefei ^a   Gu, Guosheng ^a   Li, Guanwei ^a   Liu, Song ^a   Wu, Xiuwen ^a   Chen, Jun ^a   Wu, Qin ^a   Ren, Huajian ^a   Hong, Zhiwu ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Crohn's disease; Disease activity; Inflammatory bowel disease; Red cell distribution width

Indexed keywords

C REACTIVE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; ERYTHROCYTE PARAMETERS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RED CELL DISTRIBUTION WIDTH; REMISSION; SENSITIVITY AND SPECIFICITY; BLOOD; MEAN CORPUSCULAR VOLUME; SEVERITY OF ILLNESS INDEX;

ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CROHN DISEASE; ERYTHROCYTE INDICES; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84927918363     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/maj.0000000000000334     Document Type: Article

References (24)

1. Van Assche G. The natural history of Crohn's disease: who holds the crystal ball? Gut 2012;61:1106-7.
2. Wong A, Bass D. Laboratory evaluation of inflammatory bowel disease. Curr Opin Pediatr 2008;20:566-70.
3. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006;55:426-31.
4. Swanson G, Behara R, Braun R, et al. Diagnostic medical radiation in inflammatory bowel disease: how to limit risk and maximize benefit. Inflamm Bowel Dis 2013;19:2501-8.
5. Solem CA, Loftus EV Jr, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:707-12.
6. Jones J, Loftus EV Jr, Panaccione R, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008;6:1218-24.
7. Nancey S, Hamzaoui N, Moussata D, et al. Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity. Dig Dis Sci 2008;53:242-7.
8. Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011;140:1817-26.e2.
9. Lee WS, Kim TY. Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis. Arch Pathol Lab Med 2010;134:505-6.
10. Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628-32.
11. Förhécz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 2009;158:659-66.
12. Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis 2010;16:112-24.
13. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. Gastroenterology 1976;70:439-44.
14. Song CS, Park DI, Yoon MY, et al. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease. Dig Dis Sci 2012;57:1033-8.
15. Yeşil A, Senates E, Bayoglu IV, et al. Red cell distribution width: a novel marker of activity in inflammatory bowel disease. Gut Liver 2011;5:460-7.
16. Oustamanolakis P, Koutroubakis IE, Messaritakis I, et al. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis 2011;5:295-300.
17. Cakal B, Akoz AG, Ustundag Y, et al. Red cell distribution width for assessment of activity of inflammatory bowel disease. Dig Dis Sci 2009; 54:842-7.
18. Molnar T, Farkas K, Szepes Z, et al. RDW can be a useful additional marker in diagnosing Crohn's disease and ulcerative colitis. Dig Dis Sci 2008;53:2828-9.
19. Clarke K, Sagunarthy R, Kansal S. RDW as an additional marker in inflammatory bowel disease/undifferentiated colitis. Dig Dis Sci 2008; 53:2521-3.
20. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010;4:7-27.
21. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
22. Papadaki HA, Kritikos HD, Valatas V, et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following antitumor necrosis factor-alpha antibody therapy. Blood 2002;100: 474-82.
23. Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000;118:1025-30.
24. Hansen RA, Gartlehner G, Powell GE, et al. Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 2007;5:729-35.